The Oswald Avery Award for Early Achievement recognizes outstanding achievement in an area of infectious diseases by an IDSA member or fellow who is 45 or younger (on December 31 of the year preceding the IDWeek at which the award is given). The award is based on overall achievement, not usually a single study.
Nominations
Nominees for the Oswald Avery Award for Early Achievement must be 45 or younger. Please take a moment to review the nomination application and ensure that an NIH biosketch is available to upload as a part of the nominations package.
2022 Winner: Nadine Rouphael, MD, FIDSA
Nadine Rouphael, MD, FIDSA, is a physician-scientist who has made key contributions to research on the prevention and treatment of COVID-19 and on vaccines for influenza. Dr. Rouphael has led or served as (or is currently leading or serving as) a principal investigator on more than 50 clinical trials and has served as an investigator on more than 150 clinical trials. She is currently a principal investigator on 7 NIH-funded grants and a principal investigator, co-investigator, or contract principal investigator on 15 other grants.
Dr. Rouphael is a professor of medicine in the Division of Infectious Diseases at Emory University School of Medicine, a senior physician at Emory Healthcare, and executive director of the Emory Vaccine Center Hope Clinic. The clinical arm of the Emory Vaccine Center, the Hope Clinic directs on-site vaccine clinical trials and provides translation of pre-clinical vaccine research into clinical trials in humans.
During the Adaptative COVID-19 Treatment Trials, which led to the licensure of remdesivir and the FDA approval of baricitinib, Dr. Rouphael led a team of researchers that enrolled more patients than any other site. Dr. Rouphael was Emory’s lead investigator for the phase 1 Moderna mRNA vaccine trial and the joint first author of an article in the New England Journal of Medicine. Under her leadership and working with the Grady and Emory Children Center, Emory enrolled 700 participants in the phase 3 Moderna trial. Dr. Rouphael also played a key role in the analysis of immune responses in COVID-19 patients and in defining signatures of disease severity.
Outside of COVID-19, Dr. Rouphael led a landmark study on a microneedle influenza vaccine patch and led translational research on innate immunity and systems biology using vaccines to probe the immune system. The first-in-human study showed that the microneedle influenza vaccine patch is safe, immunogenic, and preferred by patients to needles. Dr. Rouphael’s translational research was one of the first studies to show an association between antibiotic use and the decreased immunogenicity of the influenza vaccine and correlates of protection.
Currently, Dr. Rouphael is the international chair of the Sanofi clinical trial studying the safety and efficacy of adjuvanted protein COVID-19 vaccines, the international co-chair of the COVAIL clinical trial to determine optimal timing and vaccine components for the fourth COVID-19 vaccine dose, and the national chair for the Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) observational study, which is evaluating the clinical, virologic, and immunologic aspects of severe COVID-19.
Also, Dr. Rouphael is the Emory principal investigator for the NIH-funded Vaccine Treatment and Evaluation Unit and the Clinical Core principal investigator for the NIH-funded Human Immunology Project Consortium. She co-directs the Emory Stimulating Access to Research in Residency R38 Program and is the associate director of the Emory T32 vaccinology grant.
Dr. Rouphael has published more than 170 peer-reviewed research articles, including 35 articles in NEJM, Lancet, Nature, and Science. Her work has led to more than 10,000 citations. IDSA is pleased to recognize her with the 2022 Oswald Avery Award for Early Achievement.
Past Oswald Avery Award Winners
| 2021 | Michail Lionakis, MD, ScD, FIDSA |
| 2020 | Sallie R. Permar, MD, PhD |
| 2019 | Nasia Safdar, MD, MS, PhD, FIDSA, FSHEA |
| 2018 | Susanna Naggie, MD, MHS, FIDSA |
| 2017 | William J. Steinbach, MD |
| 2016 | Susan S. Huang, MD, MPH, FIDSA, FSHEA |
| 2015 | Eric R. Houpt, MD, FIDSA |
| 2014 | Sarah E. Cosgrove, MD, MS, FIDSA, FSHEA and Rochelle P. Walensky, MD, MPH, FIDSA |
| 2013 | Cesar A. Arias, MD, MSc, PhD, FIDSA |
| 2012 | Dan A. Barouch, MD, PhD |
| 2011 | Umesh Parashar, MBBS, MPH |
| 2010 | Eleftherios Mylonakis, MD, PhD, FIDSA |
| 2009 | Jean-Laurent Casanova, MD, PHD |
| 2008 | Vance G. Fowler, Jr., MD, MHS |
| 2007 | Pablo C. Okhuysen, MD, FIDSA |
| 2006 | Cynthia G. Whitney, MD, MPH |
| 2005 | James E. Crowe, MD |
| 2004 | B. Brett Finlay, PhD |
| 2003 | Joseph Heitman, MD, PhD |
| 2002 | Matthew K. Waldor, MD, PhD |
| 2001 | David A. Relman, MD |
| 2000 | Michael S. Donnenberg, MD |
| 1999 | William A. Petri, Jr., MD, PhD |
| 1998 | Joseph W. St. Geme, III, MD |
| 1997 | Samuel I. Miller, MD |
| 1996 | David D. Ho, MD |
| 1995 | Michael Osterholm, PhD, MPH |
| 1994 | Mark Klempner, MD |
| 1993 | Claire Broome, MD |
| 1992 | Martin Blaser, MD |
| 1991 | Marcus Horwitz, M.D. |
| 1990 | Jerrold Ellner, MD |
| 1989 | Henry Murray, MD |
| 1988 | Walter Stamm, MD |
| 1987 | John Gallin, MD |
| 1986 | Charles Dinarello, MD |
| 1985 | Dennis Kasper, MD |
| 1984 | Adel Mahmoud, MD, PhD |
| 1983 | Anthony Fauci, MD |
| 1982 | George Miller, PhD |
| 1981 | Gerald Keusch, MD |
| 1980 | Robert Purcell, MD |
| 1979 | Stanley Falkow, PhD |
| 1978 | King Holmes, MD, PhD |
| 1977 | Lowell Glasgow, MD, MS |
| 1976 | Sheldon Wolff, MD |
| 1975 | Kenneth Warren, MD |
| 1974 | Malcolm Artenstein, MD and Emil Gotschilch, MD |
| 1973 | Frank Austen, MD |
| 1972 | Zanvil Cohn, MD |
| 1971 | Jonathan Uhr, MD |
| 1970 | Hans Mueller-Eberhard, MD, DMSc |
| 1969 | Robert Chancock, MD |
| 1968 | Robert Good, MD, PhD |